SPONSOR
GlaxoSmithKline
Total Trials
9
Recruiting
9
Phases
Phase 3, Phase 1, Phase 2, Phase 1, Phase 2
Conditions studied: Neoplasms, LungMultiple MyelomaSystemic Lupus ErythematosusHypereosinophilic SyndromeAsthmaOvarian NeoplasmsBreast NeoplasmsStreptococcal InfectionsPulmonary Disease, Chronic ObstructiveBronchiectasis
GlaxoSmithKline is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Neoplasms, Lung, Multiple Myeloma, Systemic Lupus Erythematosus, Hypereosinophilic Syndrome.
The trial portfolio spans Phase 3, Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — GlaxoSmithKline
How many clinical trials has GlaxoSmithKline sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by GlaxoSmithKline, of which 9 are actively recruiting participants. These trials cover conditions including Neoplasms, Lung, Multiple Myeloma, Systemic Lupus Erythematosus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does GlaxoSmithKline research focus on?
GlaxoSmithKline clinical trials span Neoplasms, Lung, Multiple Myeloma, Systemic Lupus Erythematosus, Hypereosinophilic Syndrome, Asthma, and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a GlaxoSmithKline clinical trial?
To participate in a GlaxoSmithKline trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all GlaxoSmithKline trials with current recruitment status updated daily.
Clinical Trials by GlaxoSmithKline
NCT07099898 Phase 3
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Neoplasms, Lung
NCT05714839 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Multiple Myeloma
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Systemic Lupus Erythematosus
NCT05334368 Phase 3
Recruiting
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Hypereosinophilic Syndrome
NCT05757102 Phase 3
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
NCT04641247 Phase 2
Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Ovarian Neoplasms
NCT07085702 Phase 1
Recruiting
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Streptococcal Infections
NCT07177339 Phase 3
Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
NCT07201051 Phase 2
Recruiting
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Bronchiectasis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology